BackSkye Bioscience Overview

Skye Bioscience Other Current Assets

Track Skye Bioscience's other current assets ($1.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$1.46M
99.96% YoYΔ $-3.80B vs prior year quarter

Peer average

Loading

Skye Bioscience Other Current Assets History

Loading

Skye Bioscience vs. peers: Other Current Assets Comparison

Loading

Skye Bioscience Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Skye Bioscience (SKYE) FAQ

The latest other current assets for SKYE is $1.5M as of March 2026. That compares with $3.8B in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Skye Bioscience's historical trend and sector peers before judging valuation or financial health.

Over the past year, SKYE's other current assets moved from $3.8B to $1.5M — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Skye Bioscience's operating scale or balance-sheet position.

A other current assets figure of $1.5M for SKYE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SKYE's other current assets ($1.5M), review year-over-year change from $3.8B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.